摘要
目的探讨显微喉镜下摘除声带息肉实施临床路径对医疗费用控制的效果。方法选取某院2008年-2012年间实施临床路径后的309例摘除声带息肉患者为路径组和291例实施临床路径前的患者为非路径组,对患者的住院时间、住院总费用、住院药品费用、术后满意度及术后并发症率进行了比较分析。结果路径组的住院时间、住院总费用、住院药品费均低于非路径组的相应指标,各相应指标间的差异均具有统计学意义(P<0.05)。路径组与非路径组比较,平均住院时间减少了1.3天,平均住院费用减少了207.30元,平均药品费减少了175.70元,患者的术后满意度略有提高,但并不具有统计学意义(P>0.05),术后并发症发生率差异亦不具有统计学意义(P>0.05)。结论对显微喉镜下摘除声带息肉实施临床路径管理可缩短住院时间、有效控制医疗费用支出、提高患者的术后满意度,对某院耳鼻喉科实施声带息肉治疗起到了规范医疗行为的作用。
Objective To explore the effect of the clinical pathway on the control of medical costs by removing the vocal polyps. Methods The clinical data on two groups of patients treated with clinical pathway for vocal polyp（309 persons） and with regular therapies（291 persons） during 2008 and 2012 were collected. Duration of hospitalization,total cost, drug cost, postoperative satisfaction, and postoperative complication rate between two groups of patients were analyzed. Results There were significant differences in duration of hospitalization, total cost, drug cost,postoperative satisfaction, and postoperative complication rate of two grouped patients（P0.05）. Compared with patients treated with regular therapies, the average duration of hospitalization, average total cost, and average drug cost for patients treated with clinical pathway decreased by 1.3 d, 207.30 RMB Yuan, and 175.70 RMB Yuan,respectively. But there were no significant differences in postoperative satisfaction and postoperative complication rate between two groups（P0.05）. Conclusions The implementation of clinical pathway for vocal polyp could effectively decrease patients＇ average duration of hospitalization, average total cost, and average drug cost. This in turn enforced medical quality and regulating medical behavior in ENT department of the hospital.
出处
《中国病案》
2017年第11期38-39,88,共3页
Chinese Medical Record
基金
复旦大学附属金山医院院级科研资助项目(2013-6)
关键词
声带息肉
临床路径
医疗费用控制
效果评价
Vocal polyp
Clinical pathway
Medical cost controlling
Effectiveness evaluation
